相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Ascertainment of Individual Risk of Mortality for Patients with Idiopathic Pulmonary Fibrosis
Roland M. du Bois et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2011)
Clinical Course and Prediction of Survival in Idiopathic Pulmonary Fibrosis
Brett Ley et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2011)
Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials
Paul W. Noble et al.
LANCET (2011)
Six-Minute-Walk Test in Idiopathic Pulmonary Fibrosis
Roland M. du Bois et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2010)
Marginal decline in forced vital capacity is associated with a poor outcome in idiopathic pulmonary fibrosis
C. J. Zappala et al.
EUROPEAN RESPIRATORY JOURNAL (2010)
Pirfenidone in idiopathic pulmonary fibrosis
H. Taniguchi et al.
EUROPEAN RESPIRATORY JOURNAL (2010)
Effect of interferon gamma-1b on survival in patients with idiopathic pulmonary fibrosis (INSPIRE): a multicentre, randomised, placebo-controlled trial
Talmadge E. King et al.
LANCET (2009)
Small changes in six-minute walk distance are important in diffuse parenchymal lung disease
Anne E. Holland et al.
RESPIRATORY MEDICINE (2009)
Separating gains and losses in health when calculating the minimum important difference for mapped utility measures
Michael B. Nichol et al.
QUALITY OF LIFE RESEARCH (2008)
High-dose acetylcysteine in idiopathic pulmonary fibrosis
M Demedts et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Combining distribution- and anchor-based approaches to determine minimally important differences: The FACIT experience
KJ Yost et al.
EVALUATION & THE HEALTH PROFESSIONS (2005)
Double-blind, placebo-controlled trial of pirfenidone in patients with idiopathic pulmonary fibrosis
A Azuma et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2005)
Physiology is a stronger predictor of survival than pathology in fibrotic interstitial pneumonia
Y Jegal et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2005)
Analyses of efficacy end points in a controlled trial of interferon-gamma 1b for idiopathic pulmonary fibrosis
TE King et al.
CHEST (2005)
A placebo-controlled trial of interferon gamma-1b in patients with idiopathic pulmonary fibrosis
G Raghu et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Fibrotic idiopathic interstitial pneumonia - The prognostic value of longitudinal functional trends
PI Latsi et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2003)
Prognostic implications of physiologic and radiographic changes in idiopathic interstitial pneumonia
KR Flaherty et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2003)
Changes in clinical and physiologic variables predict survival in idiopathic pulmonary fibrosis
HR Collard et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2003)
Determination of the clinical importance of study results - A review
M Mon-Son-Hing et al.
JOURNAL OF GENERAL INTERNAL MEDICINE (2002)
Methods to explain the clinical significance of health status measures
GH Guyatt et al.
MAYO CLINIC PROCEEDINGS (2002)
Predicting survival in idiopathic pulmonary fibrosis: Scoring system and survival model
TE King et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2001)
分享论文
